Home › Multiple Sclerosis › Alabama › Birmingham

Pag-aaral pangklinika para sa Multiple Sclerosis sa Birmingham, AL

9 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Nagre-recruitPhase 2

UAB, Psychiatry and Behavioral Neurology, Birmingham

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Nagre-recruitObservasyonal na pag-aaral

TG Therapeutics Investigational Trial Site, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433752

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

Nagre-recruitPhase 4

Alabama Neurology Associates, Birmingham

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07609719

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Nagre-recruitPhase 2

Alabama Neurology Associates, Birmingham

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06782490

Care in Multiple Sclerosis (MS)

Nagre-recruitObservasyonal na pag-aaral

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07011914

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Nagre-recruitPhase 3

Alabama Neurology Associates- Site Number : 8400115, Homewood · 3 mi ang layo

Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07325292

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Nagre-recruitPhase 3

Alabama Neurology Associates PC, Birmingham

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

Nagre-recruit

University of Alabama at Birmingham, Birmingham

Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07475377

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

University of Alabama at Birmingham Medical Center, Birmingham

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT03759522

Pag-aaral para sa Multiple Sclerosis sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.